Takeda Pharmaceutical Co Ltd 4502.T-JP:Tokyo Stock Exchange

*Data is delayed | Exchange | JPY
Last | 3:00 PM JST
4,133.00quote price arrow down-32.00 (-0.77%)
Volume
2,527,700
52 week range
3,900.00 - 4,873.00
Loading...
  • Open4,155.00
  • Day High4,169.00
  • Day Low4,133.00
  • Prev Close4,165.00
  • 52 Week High4,873.00
  • 52 Week High Date09/15/23
  • 52 Week Low3,900.00
  • 52 Week Low Date12/18/23

Key Stats

  • Market Cap41,601.77M
  • Shares Out1,569.01M
  • 10 Day Average Volume4.31M
  • Dividend196.00
  • Dividend Yield4.74%
  • Beta0.19
  • YTD % Change1.95

KEY STATS

  • Open4,155.00
  • Day High4,169.00
  • Day Low4,133.00
  • Prev Close4,165.00
  • 52 Week High4,873.00
  • 52 Week High Date09/15/23
  • 52 Week Low3,900.00
  • 52 Week Low Date12/18/23
  • Market Cap41,601.77M
  • Shares Out1,569.01M
  • 10 Day Average Volume4.31M
  • Dividend196.00
  • Dividend Yield4.74%
  • Beta0.19
  • YTD % Change1.95

RATIOS/PROFITABILITY

  • EPS (TTM)37.00
  • P/E (TTM)111.70
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/28/2024
  • Div Amount94.00
  • Split Date-
  • Split Factor-

Latest On Takeda Pharmaceutical Co Ltd

 

Profile

MORE
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric...
Masami Iijima
Chairman of Board of Directors, Independent Director
Christophe Weber
President, Chief Executive Officer, Representative Director
Costa Saroukos
Chief Financial Officer, Director
Address
4F, 2-1-1, Nihombashihon-cho
Chuo-ku, TKY
103-8668
Japan